New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 28, 2014
08:20 EDTASTMAastrom acquisition of Sanofi assets 'makes no sense,' says Maxim
Maxim says Aastrom's (ASTM) acquisition of Sanofi's (SNY) failed efforts from Genzyme "makes no sense" given its limited resources. The firm sees the need for additional financings and it keeps a Hold rating on Aastrom.
News For ASTM From The Last 14 Days
Check below for free stories on ASTM the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for ASTM

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use